Frailty and prefrailty phenotypes increase the odds of abnormal cognitive impairment screens in people with HIV.
Journal
AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219
Informations de publication
Date de publication:
15 11 2023
15 11 2023
Historique:
medline:
26
10
2023
pubmed:
3
8
2023
entrez:
3
8
2023
Statut:
ppublish
Résumé
Evaluate whether prefrail and frail people with HIV (PWH) have a higher risk of cognitive impairment on screens. Analysis of PWH aged 70 or older included in the ANRS EP66 SEPTAVIH cohort, on antiretroviral therapy for at least 12 months and with a MoCA test at enrolment. Adjusted risk of a Montreal Cognitive Assessment (MoCA) less than 26 was compared in frail/prefrail versus robust PWH. A total of 503 PWH were enrolled with a median age of 73 years, IQR [71-77], 81.5% were male, 73.8% were French natives, 32.9% had low socio-economic status (EPICES score >30.2), and 41.3% were college graduates; 27.3% had a history of clinical AIDS. A total of 294 (58.5%) PWH had a MoCA score less than 26; 182 (36%) a MoCA score 23 or less. Frailty, prefrailty and robustness were found in 13.1, 63.6 and 23.3% participants, respectively. PWH with a MoCA less than 26 had a significantly higher risk of being frail/prefrail, this before [odds ratio (OR) = 2.31; 95% confidence interval (CI) 1.50-3.57], and after adjustment for confounders (OR = 1.80; 95% CI 1.07-3.01). The risk of being frail/prefrail in patients with a MoCA 23 or less was higher (adjusted OR = 2.75; 95% CI 1.46-5.16). Other factors independently associated with a MoCA less than 26 were older age, birth outside of France and a lower education level and being diabetic. Abnormal MoCA screens were frequent in our cohort of PWH aged 70 or older with controlled HIV disease. Cognitive impairment should be systematically screened in frail/prefrail PWH. Frailty/prefrailty, diabetes and social factors, but not HIV-related factors, are important determinants of cognitive function in PWH with controlled disease.
Identifiants
pubmed: 37534690
doi: 10.1097/QAD.0000000000003681
pii: 00002030-990000000-00318
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2161-2168Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype . J Gerontol A Biol Sci Med Sci 2001; 56:M146–M156.
Pelchen-Matthews A, Ryom L, Borges AH, Edwards S, Duvivier C, Stephan C, et al. EuroSIDA study. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort . AIDS 2018; 32:2405–2416.
Rasmussen LD, May MT, Kronborg G, Larsen CS, Pedersen C, Gerstoft J, Obel N. Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study . Lancet HIV 2015; 2:e288–e298.
Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, et al. AGEhIV Cohort Study Group. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study . Clin Infect Dis 2014; 59:1787–1797.
Althoff KN, McGinnis KA, Wyatt CM, Freiberg MS, Gilbert C, Oursler KK, et al. Veterans Aging Cohort Study (VACS). Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults . Clin Infect Dis 2015; 60:627–638.
Heron JE, Norman SM, Yoo J, Lembke K, O’Connor CC, Weston CE, et al. The prevalence and risk of noninfectious comorbidities in HIV-infected and non-HIV infected men attending general practice in Australia . PLoS One 2019; 14:e0223224.
Piggott DA, Varadhan R, Mehta SH, Brown TT, Li H, Walston JD, et al. Frailty, inflammation, and mortality among persons aging with HIV infection and injection drug use . J Gerontol A Biol Sci Med Sci 2015; 70:1542–1547.
Desquilbet L, Jacobson LP, Fried LP, Phair JP, Jamieson BD, Holloway M, Margolick JB. Multicenter AIDS Cohort Study. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty . J Gerontol A Biol Sci Med Sci 2007; 62:1279–1286.
Sharma A, Hoover DR, Shi Q, Gustafson DR, Plankey MW, Tien PC, et al. Frailty as a predictor of falls in HIV-infected and uninfected women . Antivir Ther 2019; 24:51–61.
Makinson A, Dubois J, Eymard-Duvernay S, Leclercq P, Zaegel-Faucher O, Bernard L, et al. Increased prevalence of neurocognitive impairment in aging people living with human immunodeficiency virus: the ANRS EP58 HAND 55-70 Study . Clin Infect Dis 2020; 70:2641–2648.
Kelaiditi E, Cesari M, Canevelli M, van Kan GA, Ousset PJ, Gillette-Guyonnet S, et al. IANA/IAGG. Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group . J Nutr Health Aging 2013; 17:726–734.
Cesari M, Sloane PD, Zimmerman S. The controversial condition of cognitive frailty: what it is, what it should be . J Am Med Dir Assoc 2020; 21:146–148.
Erlandson KM, Perez J, Abdo M, Robertson K, Ellis RJ, Koletar SL, et al. Frailty, neurocognitive impairment, or both in predicting poor health outcomes among adults living with human immunodeficiency virus . Clin Infect Dis 2019; 68:131–138.
Masters MC, Perez J, Wu K, Ellis RJ, Goodkin K, Koletar SL, et al. Baseline neurocognitive impairment (NCI) is associated with incident frailty but baseline frailty does not predict incident NCI in older persons with human immunodeficiency virus (HIV) . Clin Infect Dis 2021; 73:680–688.
De Francesco D, Underwood J, Bagkeris E, Boffito M, Post FA, Mallon P, et al. Pharmacokinetic and Clinical Observations in People over Fifty (POPPY) study. Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV-negative controls . HIV Med 2019; 20:274–285.
Allavena C, Blain H, Abulizi X, Slama L, Katlama C, Delobel P, et al. Prevalence and risk factors of frailty among adults living with HIV aged 70 years or older . AIDS 2023; 37:183–189.
Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment . J Am Geriatr Soc 2005; 53:695–699.
Rosca EC, Albarqouni L, Simu M. Montreal Cognitive Assessment (MoCA) for HIV-associated neurocognitive disorders . Neuropsychol Rev 2019; 29:313–327.
Milanini B, Wendelken LA, Esmaeili-Firidouni P, Chartier M, Crouch PC, Valcour V. The Montreal cognitive assessment to screen for cognitive impairment in HIV patients older than 60 years . J Acquir Immune Defic Syndr 2014; 67:67–70.
Raho-Moussa M, Guiguet M, Michaud C, Honore P, Palacios C, Boue F, et al. Respective roles of migration and social deprivation for virological nonsuppression in HIV-infected adults on antiretroviral therapy in France . PLoS One 2019; 14:e0213019.
Avila-Funes JA, Amieva H, Barberger-Gateau P, Le Goff M, Raoux N, Ritchie K, et al. Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study . J Am Geriatr Soc 2009; 57:453–461.
Boyle PA, Buchman AS, Wilson RS, Leurgans SE, Bennett DA. Physical frailty is associated with incident mild cognitive impairment in community-based older persons . J Am Geriatr Soc 2010; 58:248–255.
Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, et al. Cardiovascular Health Study. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study . Arch Intern Med 2002; 162:2333–2341.
Szlejf C, Suemoto CK, Lotufo PA, Bensenor IM. Association of sarcopenia with performance on multiple cognitive domains: results from the ELSA-Brasil Study . J Gerontol A Biol Sci Med Sci 2019; 74:1805–1811.
Persad CC, Jones JL, Ashton-Miller JA, Alexander NB, Giordani B. Executive function and gait in older adults with cognitive impairment . J Gerontol A Biol Sci Med Sci 2008; 63:1350–1355.
Ambrose AF, Noone ML, Pradeep VG, Johnson B, Salam KA, Verghese J. Gait and cognition in older adults: insights from the Bronx and Kerala . Ann Indian Acad Neurol 2010; 13: (Suppl 2): S99–S103.
Montero-Odasso MM, Barnes B, Speechley M, Muir Hunter SW, Doherty TJ, Duque G, et al. Disentangling cognitive-frailty: results from the gait and brain study . J Gerontol A Biol Sci Med Sci 2016; 71:1476–1482.
Woo J, Leung J, Morley JE. Validating the SARC-F: a suitable community screening tool for sarcopenia? . J Am Med Dir Assoc 2014; 15:630–634.
Goodkin K, Miller EN, Cox C, Reynolds S, Becker JT, Martin E, et al. Multicenter AIDS Cohort Study. Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study . Lancet HIV 2017; 4:e411–e422.
Damas J, Ledergerber B, Nadin I, Tarr PE, Stoeckle M, Kunze U, et al. Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well treated HIV . AIDS 2021; 35:2469–2480.
Dufouil C, Richert L, Thiebaut R, Bruyand M, Amieva H, Dauchy FA, et al. ANRS CO3 Aquitaine Study Group. Diabetes and cognitive decline in a French cohort of patients infected with HIV-1 . Neurology 2015; 85:1065–1073.
McCutchan JA, Marquie-Beck JA, Fitzsimons CA, Letendre SL, Ellis RJ, Heaton RK, et al. CHARTER Group. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder . Neurology 2012; 78:485–492.
Wu M, Fatukasi O, Yang S, Alger J, Barker PB, Hetherington H, et al. Neuropsychology Working Group of the Multicenter AIDS Cohort Study. HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition . AIDS 2018; 32:1803–1810.
Lipnicki DM, Crawford JD, Dutta R, Thalamuthu A, Kochan NA, Andrews G, et al. Cohort Studies of Memory in an International Consortium (COSMIC). Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethnocultural groups and geographic regions: a collaborative cohort study . PLoS Med 2017; 14:e1002261.
Spooner R, Ranasinghe S, Urasa S, Yoseph M, Koipapi S, Mukaetova-Ladinska EB, et al. HIV-associated neurocognitive disorders: the first longitudinal follow-up of a cART-treated cohort of older people in Sub-Saharan Africa . J Acquir Immune Defic Syndr 2022; 90:214–222.
Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 Recommendations of the International Antiviral Society-USA Panel . JAMA 2020; 324:1651–1669.
Clegg A, Barber S, Young J, Iliffe S, Forster A. The Home-based Older People's Exercise (HOPE) trial: a pilot randomised controlled trial of a home-based exercise intervention for older people with frailty . Age Ageing 2014; 43:687–695.
de Vries NM, van Ravensberg CD, Hobbelen JS, Olde Rikkert MG, Staal JB, Nijhuis-van der Sanden MW. Effects of physical exercise therapy on mobility, physical functioning, physical activity and quality of life in community-dwelling older adults with impaired mobility, physical disability and/or multimorbidity: a meta-analysis . Ageing Res Rev 2012; 11:136–149.
Ellis G, Gardner M, Tsiachristas A, Langhorne P, Burke O, Harwood RH, et al. Comprehensive geriatric assessment for older adults admitted to hospital . Cochrane Database Syst Rev 2017; 9:CD006211.
Livelli A, Orofino GC, Calcagno A, Farenga M, Penoncelli D, Guastavigna M, et al. Evaluation of a cognitive rehabilitation protocol in HIV patients with associated neurocognitive disorders: efficacy and stability over time . Front Behav Neurosci 2015; 9:306.
Sherman DS, Durbin KA, Ross DM. Meta-analysis of memory-focused training and multidomain interventions in mild cognitive impairment . J Alzheimers Dis 2020; 76:399–421.